Neogen stock kpis
Want to see NEOG full AI Analyst Report?
Revenue by Segment
Neogen reported revenue by segment of $222.80M in Q2 FY2027, down 1.1% from Q1 FY2027 and up 6.5% year over year. The highest value was $241.81M in Q1 FY2024.
Analyzes revenue generated by different business segments, providing a clear picture of which divisions are contributing most to growth and overall financial health.
Food Safety has permanently re‑scaled since late‑2022 into Neogen’s clear revenue engine, delivering consistently larger, stable quarterly contributions that now insulate overall top‑line growth; that step‑up reads like a structural change (acquisition or new product adoption) rather than a brief spike. Animal Safety, by contrast, has softened and grown more volatile since 2023, implying end‑market weakness or pricing/competitive pressure—a concentration risk if Food Safety’s gains aren’t clearly organic and repeatable.
NEOG Revenue by Segment
| Period | Food Safety | Animal Safety | Total |
|---|---|---|---|
| Q2 FY2027Sep 30, 2026 | $163.20M | $59.60M | $222.80M |
| Q1 FY2027Jun 30, 2026 | $166.80M | $58.52M | $225.32M |
| Q4 FY2026Mar 31, 2026 | $156.70M | $54.50M | $211.20M |
| Q3 FY2026Dec 31, 2025 | $165.55M | $59.14M | $224.69M |
| Q2 FY2026Sep 30, 2025 | $152.05M | $57.14M | $209.19M |
| Q1 FY2026Jun 30, 2025 | $161.83M | $63.63M | $225.46M |
| Q4 FY2025Mar 31, 2025 | $152.73M | $68.25M | $220.98M |
| Q3 FY2025Dec 31, 2024 | $164.24M | $67.02M | $231.26M |
| Q2 FY2025Sep 30, 2024 | $159.34M | $57.62M | $216.96M |
| Q1 FY2025Jun 30, 2024 | $166.91M | $69.89M | $236.79M |
| Q4 FY2024Mar 31, 2024 | $157.75M | $71.06M | $228.81M |
| Q3 FY2024Dec 31, 2023 | $164.40M | $65.23M | $229.63M |
| Q2 FY2024Sep 30, 2023 | $166.28M | $62.71M | $228.99M |
| Q1 FY2024Jun 30, 2023 | $169.27M | $72.54M | $241.81M |
| Q4 FY2023Mar 31, 2023 | $151.54M | $66.71M | $218.25M |
| Q3 FY2023Dec 31, 2022 | $161.34M | $68.69M | $230.03M |
| Q2 FY2023Sep 30, 2022 | $64.64M | $67.71M | $132.35M |
| Q1 FY2023Jun 30, 2022 | $67.37M | $72.72M | $140.09M |
| Q4 FY2022Mar 31, 2022 | $62.76M | $65.49M | $128.24M |
| Q3 FY2022Dec 31, 2021 | $67.13M | $63.38M | $130.52M |
| Q2 FY2022Sep 30, 2021 | $62.72M | $65.58M | $128.31M |
| Q1 FY2022Jun 30, 2021 | $62.10M | $63.32M | $125.42M |
| Q4 FY2021Mar 31, 2021 | $58.42M | $58.28M | $116.71M |
| Q3 FY2021Dec 31, 2020 | $57.53M | $57.47M | $115.00M |
| Q2 FY2021Sep 30, 2020 | $54.19M | $55.14M | $109.33M |

